Pharmacological experiments indicated that interference with PCAF expression in Huh 7 HCC cells decreased the sensitivity to 5-FU and oxaliplatin (Fig. 4C); however, overexpression of PCAF attenuated the resistance to chemotherapy induced by TET2 knockdown (Fig. 4D). The gene discussed is KAT2B; the disease is hepatocellular carcinoma.